The possibility of lifestyle and biological risk markers to predict morbidity and mortality in a cohort of young men after 26 years follow-up

Lars-Göran Persson, Hans Lingfors, Mats Nilsson, Sigvard Mölstad, Lars-Göran Persson, Hans Lingfors, Mats Nilsson, Sigvard Mölstad

Abstract

Objectives: To study the association between lifestyle and biological risk markers measured at one occasion, morbidity and mortality from cardiovascular disease (CVD) and cancer, and morbidity from diabetes approximately 26 years later.

Design: A follow-up study of a cohort of men, 33-42 years old at baseline.

Setting: Primary healthcare centre in Sweden.

Participants: All 757 men, living in the community of Habo in Sweden in 1985, and all 652 of these participating in a health examination in 1985-1987.

Interventions: Health profile and a health dialogue with a nurse. A doctor invited the high-risk group to further dialogue and examination. Intervention programmes were carried out in the primary healthcare centre and in cooperation with local associations.

Main outcome measures: CVD and cancer diagnoses from the Swedish National Board of Health and Welfare. Data from pharmacy registers of sold drugs concerning diabetes mellitus.

Results: The participants were divided in three groups based on summarised risk points from lifestyle (smoking, physical activity, alcohol consumption) and biological risk markers (body mass index (BMI), blood pressure, serum cholesterol) selected from the health profile. Comparisons were done between these groups. The group with the lowest summarised total risk points had a significantly lower risk for CVD and cancer compared with the group with the highest summarised risk points. The group with the lowest risk points concerning lifestyle had a significantly lower risk for CVD, and the group with lowest risk points for biological risk markers had a significantly lower risk for both CVD and cancer compared with the groups with the highest risk points. Smoking and serum cholesterol were the most important risk factors. In association to diabetes, BMI and smoking were the most important risk factors.

Conclusions: Risk factors measured on one occasion seemed to be able to predict CVD, cancer and diabetes 26 years later.

Keywords: EPIDEMIOLOGY; PREVENTIVE MEDICINE; PRIMARY CARE.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

References

    1. La Vecchia C, Levi F, Lucchini F et al. . Trends in mortality from major diseases in Europe, 1980–1993. Eur J Epidemiol 1998;14:1–8. 10.1023/A:1007440201137
    1. Sveriges officiella statistik. Statistik—Hälso- och Sjukvaård. Doödsorsaker 2012. [Official statistics of Sweden. Statistics—Health and Medical Care. Causes of Death 2012]. English summery. Stockholm: Socialstyrelsen, 2013.
    1. Yusuf S, Hawken S, Ounpuu S et al. . Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937–52. 10.1016/S0140-6736(04)17018-9
    1. O'Donnell MJ, Xavier D, Liu L et al. . Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010;376:112–23. 10.1016/S0140-6736(10)60834-3
    1. Coyle YM. Lifestyle, genes, and cancer. Methods Mol Biol 2009;472:25–56. 10.1007/978-1-60327-492-0_2
    1. Khan N, Afaq F, Mukhtar H. Lifestyle as risk factor for cancer: evidence from human studies. Cancer Lett 2010;293:133–43. 10.1016/j.canlet.2009.12.013
    1. Conroy RM, Pyorala K, Fitzgerald AP et al. . Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987–1003. 10.1016/S0195-668X(03)00114-3
    1. Wilhelmsen L, Wedel H, Conroy R et al. . [The Swedish SCORE chart for cardiovascular risk. Better possibilities for prevention of cardiovascular diseases]. Lakartidningen 2004;101:1798–801.
    1. Perk J, De Backer G, Gohlke H et al. . [European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)]. G Ital Cardiol (Rome) 2013;14:328–92. 10.1714/1264.13964
    1. Persson LG, Lindström K, Lingfors H et al. . A study of men aged 33–42 in Habo, Sweden with special reference to cardiovascular risk factors. Design, health profile and characteristics of participants and non-participants. Scand J Soc Med 1994;22:264–72.
    1. Doll R, Peto R, Boreham J et al. . Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ 2004;328:1519 10.1136/
    1. Strandberg TE, Salomaa VV, Vanhanen HT et al. . Blood pressure and mortality during an up to 32-year follow-up. J Hypertens 2001;19:35–9. 10.1097/00004872-200101000-00005
    1. Goldbourt U, Yaari S, Medalie JH. Factors predictive of long-term coronary heart disease mortality among 10,059 male Israeli civil servants and municipal employees. A 23-year mortality follow-up in the Israeli Ischemic Heart Disease Study. Cardiology 1993;82:100–21. 10.1159/000175862
    1. Clarke R, Emberson J, Fletcher A et al. . Life expectancy in relation to cardiovascular risk factors: 38 year follow-up of 19,000 men in the Whitehall study. BMJ 2009;339:b3513 10.1136/bmj.b3513
    1. Wannamethee SG, Shaper AG, Whincup PH et al. . Role of risk factors for major coronary heart disease events with increasing length of follow up. Heart 1999;81:374–9.
    1. Saltin B, Grimby G. Physiological analysis of middle-aged and old former athletes. A comparision with still active athletes of the same ages. Circulation 1968;38:1104–15. 10.1161/01.CIR.38.6.1104
    1. Persson LG, Lindström K, Lingfors H et al. . Results from an intervention programme dealing with cardiovascular risk factors. Experiences from a study of men aged 33–42 in Habo, Sweden. Scand J Prim Health Care 1996;14:184–92. 10.3109/02813439609024175
    1. Wilhelmsen L, Welin L, Svardsudd K et al. . Secular changes in cardiovascular risk factors and attack rate of myocardial infarction among men aged 50 in Gothenburg, Sweden. Accurate prediction using risk models. J Intern Med 2008;263:636–43. 10.1111/j.1365-2796.2008.01931.x
    1. Larsen SB, Dalton SO, Schuz J et al. . Mortality among participants and non-participants in a prospective cohort study. Eur J Epidemiol 2012;27:837–45. 10.1007/s10654-012-9739-x
    1. Strandberg TE, Salomaa VV, Vanhanen HT et al. . Mortality in participants and non-participants of a multifactorial prevention study of cardiovascular diseases: a 28 year follow up of the Helsinki Businessmen Study. Br Heart J 1995;74:449–54. 10.1136/hrt.74.4.449
    1. The Health Consequences of Smoking—50 Years of Progress. A report of the Surgeon General. Executive summery. Atlanta, GA, USA: Department of Health and Human Services, Centers for Disease Control and Prevention, 2014.
    1. Rosengren A, Wilhelmsen L. Physical activity protects against coronary death and deaths from all causes in middle-aged men. Evidence from a 20-year follow-up of the primary prevention study in Goteborg. Ann Epidemiol 1997;7:69–75. 10.1016/S1047-2797(96)00106-8
    1. Sofi F, Capalbo A, Cesari F et al. . Physical activity during leisure time and primary prevention of coronary heart disease: an updated meta-analysis of cohort studies. Eur J Cardiovasc Prev Rehabil 2008;15:247–57. 10.1097/HJR.0b013e3282f232ac
    1. Menotti A, Giampaoli S. A single risk factor measurement predicts 35-year mortality from cardiovascular disease. G Ital Cardiol 1998;28:1354–62.
    1. Miura K, Daviglus ML, Dyer AR et al. . Relationship of blood pressure to 25-year mortality due to coronary heart disease, cardiovascular diseases, and all causes in young adult men: the Chicago Heart Association Detection Project in Industry. Arch Intern Med 2001;161:1501–8. 10.1001/archinte.161.12.1501
    1. Wilkins JT, Ning H, Berry J et al. . Lifetime risk and years lived free of total cardiovascular disease. JAMA 2012;308:1795–801. 10.1001/jama.2012.14312
    1. Persson LG, Lindström K, Lingfors H et al. . Cardiovascular risk during early adult life. Risk markers among participants in “Live for Life” health promotion programme in Sweden. J Epidemiol Community Health 1998;52:425–32. 10.1136/jech.52.7.425
    1. Lingfors H, Persson LG, Lindström K et al. . Time for a “vision zero” concerning premature death from ischaemic heart disease? Scand J Prim Health Care 2002;20:28–32. 10.1080/028134302317282707
    1. Long GH, Simmons RK, Norberg M et al. . Temporal shifts in cardiovascular risk factor distribution. Am J Prev Med 2014;46:112–21. 10.1016/j.amepre.2013.10.011
    1. Norberg M, Wall S, Boman K et al. . The Västerbotten Intervention Programme: background, design and implications. Glob Health Action 2010;3:1–15 10.3402/gha.v3i0.4643

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj